Health
Biocompatible photooxygenation catalyst could be potentially used to treat amyloid diseases – News-Medical.Net
A new, biocompatible photooxygenation catalyst that can selectively oxygenate and degrade the pathogenic aggregation of Alzheimer’s disease (AD)-related amyloid-β…
Reviewed by Emily Henderson, B.Sc.Nov 25 2020
A new, biocompatible photooxygenation catalyst that can selectively oxygenate and degrade the pathogenic aggregation of Alzheimer’s disease (AD)-related amyloid-β peptide (Aβ) under near-infrared (NIR) light irradiation is developed.
The catalyst was able to oxygenate Aβ embedded under the skin of a living mouse, and diminished intact Aβ level in AD-model mouse brain. The new catalyst is potentially applicable for the treatment of peripheral amyloid…
-
Business23 hours agoThese ASX 200 shares could rise 50% to 60%
-
General23 hours agoAustralia’s Myanmar community mourns earthquake losses
-
General21 hours agoPeter Dutton partially walks back public service work-from-home vow
-
Noosa News20 hours agoDisaster relief packages announced for flood-stricken western Queensland